Inventor
Brian Seed
Inventor
Boston, MA, US
Overview
Patents· 75 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides22%
A61KPreparations for medical, dental or toiletry purposes21%
C12NMicroorganisms or enzymes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07HSugars7%
C07DHeterocyclic compounds6%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
10,981,942Crystalline form of benzylbenzene SGLT2 inhibitor202110,533,032Crystalline form of benzylbenzene SGLT2 inhibitor20209,834,573Crystalline form of benzylbenzene SGLT2 inhibitor20179,725,478'Process for the preparation of benzylbenzene SGLT2 inhibitors'20179,493,747'Engineered transglutaminase barrel proteins'20169,340,584'Engineered thioredoxin-like fold proteins'20169,193,751'Process for the preparation of benzylbenzene SGLT2 inhibitors'20159,061,060'Deuterated benzylbenzene derivatives and methods of use'20158,993,295'Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting'20158,987,323'Crystalline form of benzylbenzene SGLT2 inhibitor'20158,802,637'Benzylbenzene derivatives and methods of use'20148,748,419'Treating obesity with muscarinic receptor M1 antagonists'20148,735,389'Treating psychological conditions using muscarinic receptor M1 antagonists'20148,575,321'Benzylbenzene derivatives and methods of use'20138,524,241'Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A'20138,440,655'Combination therapy for the treatment of diabetes'20138,420,094'Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A'20138,129,434'Benzylphenyl cyclohexane derivatives and methods of use'20128,106,021'Benzylbenzene derivatives and methods of use'20127,893,053'Treating psychological conditions using muscarinic receptor M1 antagonists'20117,838,498'Benzylic glycoside derivatives and methods of use'20107,838,499'Benzylbenzene derivatives and methods of use'20107,803,778'Glucose transport inhibitors and methods of use'20107,795,228'Spiroheterocyclic glycosides and methods of use'20107,518,033'Methods for the production of cells and mammals with desired genetic modifications'20097,399,847'Nucleic acids encoding artificial P-selectin ligands'20087,320,787'Redirection of cellular immunity by protein tyrosine kinase chimeras'20087,259,009'Self-rearranging DNA vectors'20077,253,264'Immunoglobulin fusion proteins, their production and use'20077,119,183'Rapid immunoselection cloning method'20067,109,206'Methods and compositions for the rapid and enduring relief of inadequate myocardial function'20067,094,599'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells'20067,049,136'Redirection of cellular immunity by receptor chimeras'20066,753,162'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells'20046,719,977'Methods to potentiate cancer therapies'20046,613,746'AGP-antibody fusion proteins and related molecules and methods'20036,579,676'Rapid mutational analysis method and compositions'20036,410,014'Redirection of cellular immunity by protein-tyrosine kinase chimeras'20026,392,013'Redirection of cellular immunity by protein tyrosine kinase chimeras'20026,284,240'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells'20016,218,525'Nucleic acid encoding CD28'20016,159,993'Methods and compositions for the rapid and enduring relief of inadequate myocardial function'20006,156,881'Inhibition of cell adhesion protein-carbohydrate interactions'20006,133,025'Compact Epstein-Barr virus replicons'20006,117,656'Cloned genes encoding IG-CD4 fusion proteins and the use thereof'20006,114,148'High level expression of proteins'20006,111,093'CD19 coding sequences'20006,093,558'Binding protein of biologically active compositions to an adhesive formulation on a substrate'20006,004,811'Redirection of cellular immunity by protein tyrosine kinase chimeras'19996,004,781'Nucleic acid encoding Ig-CD4 fusion proteins'19995,955,264'Rapid mutational analysis method'19995,925,657'Use of PPAR.gamma. agonists for inhibition of inflammatory cytokine production'19995,912,170'Redirection of cellular immunity by protein-tyrosine kinase chimeras'19995,861,399'Methods and compositions for the rapid and enduring relief of inadequate myocardial function'19995,858,983'Inhibition of cell adhesion protein-carbohydrate interactions'19995,858,752'Fucosyltransferase genes and uses thereof'19995,851,828'Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells'19985,849,898'CD40 coding sequences'19985,843,728'Redirection of cellular immunity by receptor chimeras'19985,830,731'Cloning vector, polylinker and methods'19985,801,044'Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions'19985,795,737'High level expression of proteins'19985,786,464'Overexpression of mammalian and viral proteins'19985,726,293'Affinity purification methods involving imidazole elution'19985,723,583'Antibody containing sialyl lewis X determinants'19985,674,734'Cell death protein'19975,656,592'Use of relaxin as an analgesic and palliative for intractable pain'19975,547,660'Nail lacquer composition containing poly-hydroxystyrene'19965,506,126'Rapid immunoselection cloning method'19965,420,264'Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof'19955,411,861'Rapid mutational analysis method'19955,358,857'Method of preparing fusion proteins'19945,227,293'Fusion proteins, their preparation and use'19935,081,034'Cloned genes which encode ELAM-1'19924,286,964'Polyfunctional epoxides and halohydrins used as bridging groups to bind aromatic amine group-containing alcohols and thiols to hydroxyl bearing substrates'1981Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1981Based in Scarsdale, NY, US· patent location history
1992–2016Patents assigned to GEN HOSPITAL CORP (46)· patent assignee history
1992–2021Based in Boston, MA, US· patent location history
2007–2012Based in Derry, NH, US· patent location history
2010–2015Patents assigned to THERACOS INC (15)· patent assignee history
2012–2016Patents assigned to SEED BRIAN (12)· patent assignee history
2012–2015Patents assigned to LV BINHUA (5)· patent assignee history
2012–2015Patents assigned to CHEN YUANWEI (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GEN HOSPITAL CORP | 46 | 1992–2016 |
| THERACOS INC | 15 | 2010–2015 |
| SEED BRIANself | 12 | 2012–2016 |
| LV BINHUA | 5 | 2012–2015 |
| CHEN YUANWEI | 4 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boston, Massachusetts, US | 69 | 1992–2021 |
| Derry, NH, US | 5 | 2007–2012 |
| Scarsdale, New York, US | 1 | 1981 |